A US based clinical research support organization, comprised of three vertically integrated companies. The three companies provide industry leading support via their services and products to pharmaceutical, biotech, and device companies.
Strategy was to expand its international footprint in one if it’s divisions.
As a global organisation, fulfilment is a vital part of the process; the company’s logistics staff executes more than 50,000 shipments annually to over 100 countries. Products and services range from PRO documents, to fulfilment of ancillary supplies, to site kit creative development and production, to global logistics. Supplying materials for clinical trials on this scale requires a robust infrastructure and the company has a large number of supply contracts around Europe.
It made sense for them to create a European “hub” that would handle print production and logistics for its clinical trial materials, ideally in the UK. Rather than set up a business in the UK from scratch the acquirer decided to acquire an existing print and fulfilment business.
The Company’s President, wanted to use an M&A intermediary for the acquisition to minimise the demands on his staff. Far preferable to use an in-country company to research and approach a list of targets.
